234 related articles for article (PubMed ID: 24062447)
1. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1.
Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY
Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698
[TBL] [Abstract][Full Text] [Related]
3. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation.
Wang T; Nandakumar V; Jiang XX; Jones L; Yang AG; Huang XF; Chen SY
Blood; 2013 Oct; 122(16):2812-22. PubMed ID: 24014243
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation of Antibody Responses by the Histone H2A Deubiquitinase MYSM1.
Jiang XX; Chou Y; Jones L; Wang T; Sanchez S; Huang XF; Zhang L; Wang C; Chen SY
Sci Rep; 2015 Sep; 5():13755. PubMed ID: 26348977
[TBL] [Abstract][Full Text] [Related]
5. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
[TBL] [Abstract][Full Text] [Related]
6. Control of B cell development by the histone H2A deubiquitinase MYSM1.
Jiang XX; Nguyen Q; Chou Y; Wang T; Nandakumar V; Yates P; Jones L; Wang L; Won H; Lee HR; Jung JU; Müschen M; Huang XF; Chen SY
Immunity; 2011 Dec; 35(6):883-96. PubMed ID: 22169041
[TBL] [Abstract][Full Text] [Related]
7. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.
Gascoyne DM; Long E; Veiga-Fernandes H; de Boer J; Williams O; Seddon B; Coles M; Kioussis D; Brady HJ
Nat Immunol; 2009 Oct; 10(10):1118-24. PubMed ID: 19749763
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression.
Male V; Nisoli I; Kostrzewski T; Allan DS; Carlyle JR; Lord GM; Wack A; Brady HJ
J Exp Med; 2014 Apr; 211(4):635-42. PubMed ID: 24663216
[TBL] [Abstract][Full Text] [Related]
9. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase Mysm1 regulates neural stem cell proliferation and differentiation by controlling Id4 expression.
Xu Z; Qin Q; Wang Y; Zhang H; Liu S; Li X; Chen Y; Wang Y; Ruan H; He W; Zhang T; Yan X; Wang C; Xu D; Jiang X
Cell Death Dis; 2024 Feb; 15(2):129. PubMed ID: 38342917
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review.
Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625
[TBL] [Abstract][Full Text] [Related]
13. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8
Förster M; Boora RK; Petrov JC; Fodil N; Albanese I; Kim J; Gros P; Nijnik A
Immunology; 2017 May; 151(1):110-121. PubMed ID: 28066899
[TBL] [Abstract][Full Text] [Related]
14. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
[TBL] [Abstract][Full Text] [Related]
15. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency.
Belle JI; Langlais D; Petrov JC; Pardo M; Jones RG; Gros P; Nijnik A
Blood; 2015 Apr; 125(15):2344-8. PubMed ID: 25710881
[TBL] [Abstract][Full Text] [Related]
16. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A
Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548
[TBL] [Abstract][Full Text] [Related]
17. 2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs.
Wilms C; Krikki I; Hainzl A; Kilo S; Alupei M; Makrantonaki E; Wagner M; Kroeger CM; Brinker TJ; Gatzka M
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495602
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
[TBL] [Abstract][Full Text] [Related]
19. The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15.
Delconte RB; Shi W; Sathe P; Ushiki T; Seillet C; Minnich M; Kolesnik TB; Rankin LC; Mielke LA; Zhang JG; Busslinger M; Smyth MJ; Hutchinson DS; Nutt SL; Nicholson SE; Alexander WS; Corcoran LM; Vivier E; Belz GT; Carotta S; Huntington ND
Immunity; 2016 Jan; 44(1):103-115. PubMed ID: 26795246
[TBL] [Abstract][Full Text] [Related]
20. MYSM1-dependent checkpoints in B cell lineage differentiation and B cell-mediated immune response.
Förster M; Farrington K; Petrov JC; Belle JI; Mindt BC; Witalis M; Duerr CU; Fritz JH; Nijnik A
J Leukoc Biol; 2017 Mar; 101(3):643-654. PubMed ID: 27895164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
